Use of Remdesivir in the treatment of Covid-19: na integrative review

The present study aimed to determine the efficacy, effectiveness and safety of Remdesivir in the treatment of Covid-19 through an integrative review. The search for articles was carried out in March 2021 in the Pubmed, Scielo, Embase and Cochrane databases. To guide this research, the guiding questi...

ver descrição completa

Detalhes bibliográficos
Autores: Malacrida, Gabrielly Alves, Santos, Gabriel Henrique Maximino, Pereira, Valéria Cataneli, Keller, Rogéria
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2022
País:Brasil
Recursos:Universidade Federal de Itajubá (UNIFEI)
Repositorio:Research, Society and Development
Idioma:portugués
OAI Identifier:oai:ojs.pkp.sfu.ca:article/26420
Acesso em linha:https://rsdjournal.org/index.php/rsd/article/view/26420
Access Level:acceso abierto
Palavra-chave:Covid-19
Sars-CoV-2
Coronavírus
Treatment
Remdesivir
Pandemic
Review.
Tratamento
Pandemia
Revisão.
Tratamiento
Revisión.
Descrição
Resumo:The present study aimed to determine the efficacy, effectiveness and safety of Remdesivir in the treatment of Covid-19 through an integrative review. The search for articles was carried out in March 2021 in the Pubmed, Scielo, Embase and Cochrane databases. To guide this research, the guiding question was raised: “What is the role of Remdesivir in the treatment of Covid-19 in humans?”. The descriptors “Covid or Sars-Cov-2 or Coronavirus” and “treatment” and “Remdesivir” were used. Inclusion criteria were original primary studies that addressed the proposed topic, available in full, between 2019-2021, in Portuguese or English. Of the 3012 articles found, 17 were used that met the inclusion criteria. Most of the studies found reported an improvement in the condition of patients treated with Remdesivir, but it is important to note that therapy with the drug also had several side effects and did not change the mortality rate. Based on the data analyzed, Remdesivir showed promising results, suggesting a favorable risk-benefit profile, but as far as was observed, the rate of deaths was not altered and its prolonged use can trigger undesirable side effects.